Tesamorelin vs Sermorelin — Research Comparison
⚠ Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not for human consumption, therapeutic use, or clinical application. Buyers must comply with all applicable local laws and regulations.
A research reference comparing Tesamorelin and Sermorelin — GHRH analogue research comparison — visceral fat vs GH pulse. This comparison is for scientific research reference only.
Side-by-Side Comparison
| Property | Tesamorelin | Sermorelin |
| CAS Number | 218949-48-5 | 86168-78-7 |
| Category | GH Peptide | GH Peptide |
| Research Use | GHRH analogue and visceral fat reduction research | growth hormone releasing hormone analogue research |
| Purity (Aarise) | 98%+ HPLC | 98%+ HPLC |
| Form | Lyophilised powder | Lyophilised powder |
Research Applications
Tesamorelin is primarily studied for GHRH analogue and visceral fat reduction research. Sermorelin is studied for growth hormone releasing hormone analogue research. Researchers choose between these compounds based on their specific experimental model and endpoints.
Source Both Compounds from Aarise Healthcare
Aarise Healthcare supplies both Tesamorelin and Sermorelin at 98%+ purity from our WHO-GMP certified facility. Order both compounds together for consistent quality across your comparative research programme.
Request pricing for Tesamorelin and Sermorelin: Contact our research supply team with your quantity requirements. We respond within 24 hours.




